Why venlafaxine is particularly difficult to stop
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI), prescribed for depression, anxiety disorders, generalised anxiety and panic disorder. It is effective for many people — but its very short half-life (around 5 hours for the immediate-release formulation; slightly longer for extended-release) means that changes in blood levels are felt rapidly by the nervous system.
Many people taking venlafaxine notice withdrawal-like symptoms — dizziness, nausea, brain zaps — if they simply miss a single dose. This is not an overreaction. It reflects how sensitively the nervous system responds to fluctuations in this particular medication.
Stopping venlafaxine after long-term use without a properly planned taper is one of the most common causes of severe and prolonged antidepressant withdrawal we see in clinical practice.
Venlafaxine withdrawal symptoms
The withdrawal profile of venlafaxine is well-documented and is considered one of the most intense of any antidepressant. Symptoms typically begin within hours of a missed or reduced dose and can include:
- Brain zaps — electric shock-like sensations in the head or body, often triggered by eye movement
- Severe dizziness and vertigo — can make it difficult to function day to day
- Nausea and vomiting — particularly in the first few days of a reduction
- Intense anxiety and agitation — often disproportionate to circumstances
- Flu-like symptoms — sweating, chills, muscle aches
- Sleep disruption — vivid nightmares, insomnia, restlessness
- Mood instability — emotional flooding, tearfulness, irritability
- Cognitive effects — confusion, difficulty concentrating, memory gaps
- Sensory hypersensitivity — heightened sensitivity to light, sound and touch
These symptoms can be frightening and can significantly disrupt daily life. They are, however, manageable with a sufficiently slow and properly supported taper.
The challenge of venlafaxine formulations
Venlafaxine is available in immediate-release tablets (37.5mg, 75mg) and extended-release capsules (75mg, 150mg). The extended-release (XR or XL) formulation is more commonly prescribed in the UK and is somewhat easier to manage during tapering because it smooths out the peaks and troughs in blood concentration.
However, both formulations present a significant challenge at lower doses: the smallest available tablet is 37.5mg, which is far too large a step for many people tapering from 75mg or less. Standard tablet cutting is often insufficient at the lower end of the taper.
Strategies we use to manage this include:
- Switching from XR capsules to immediate-release tablets to allow more granular dose control
- Opening capsules and counting beads to achieve very small dose reductions
- Using compounding pharmacies to prepare liquid formulations or smaller dose capsules
- Switching to fluoxetine (which has a very long half-life) for the final stages of tapering, then tapering fluoxetine — a recognised clinical strategy for severe venlafaxine discontinuation
Key points about stopping venlafaxine
- Never stop venlafaxine abruptly — withdrawal symptoms can begin within hours and can be severe
- Standard two-to-four week tapers are far too fast for most long-term users
- The smallest commercially available dose (37.5mg) is often still too large for the final stages of tapering
- Switching formulations or using compounding pharmacies may be necessary for precise low-dose control
- A fluoxetine bridge is a recognised option for people who cannot tolerate venlafaxine reduction
- With the right plan, most people can stop venlafaxine successfully — it simply takes longer than most expect
How long does venlafaxine tapering take?
There is no single answer — it depends on the dose, the duration of use, the individual's sensitivity and how the nervous system responds at each stage. As a general guide:
- People on venlafaxine for less than a year at a lower dose may complete a taper in three to six months
- People on venlafaxine for several years at doses of 150mg or above should realistically plan for twelve to twenty-four months
- People who have experienced severe withdrawal in a previous attempt, or who have very high sensitivity, may need longer
These timelines can feel long. But they reflect what the nervous system needs — and attempting to rush them consistently leads to distress, reinstatement and having to start again.
What if I have tried to stop before?
Most people who come to us for venlafaxine support have tried to stop at least once before — often on the basis of GP advice to reduce over two to four weeks — and found the experience overwhelming. Some have reinstated multiple times. This does not mean the medication is needed permanently. It means previous attempts lacked the pace, the planning or the clinical support that this particular medication requires.
We see this regularly and we know how disheartening those experiences can be. A properly planned, properly supported taper is a very different experience from an unstructured one.
Important
Do not attempt to stop venlafaxine abruptly or without medical supervision. Abrupt discontinuation can cause severe and potentially dangerous withdrawal symptoms. If you have already stopped abruptly and are experiencing severe symptoms, contact your GP or call 111.
For GPs considering referral
Venlafaxine is one of the most challenging antidepressants to deprescribe and frequently exceeds what primary care can safely support without specialist input. We provide full psychiatric assessment, a bespoke taper protocol, and ongoing monitoring for patients referred for venlafaxine reduction. We can advise on formulation switches, bead-counting protocols and fluoxetine bridging where appropriate. We issue private prescriptions as needed and communicate at each stage with the referring GP.
Our approach
How we support venlafaxine reduction
We have significant experience supporting people through venlafaxine reduction — including those for whom previous attempts have failed. Our approach begins with a full assessment of your psychiatric history, your dose and duration, your previous experiences of dose reduction, and your current stability.
We then build a taper plan that accounts for the specific challenges of venlafaxine, including formulation strategy at lower doses. We do not use a standard template. Every plan is built around the individual.
- Full psychiatric assessment before any reduction begins
- Bespoke hyperbolic taper plan accounting for venlafaxine's specific pharmacology
- Clinical advice on formulation — tablets vs capsules, bead counting, compounding options
- Fluoxetine bridging strategy where clinically appropriate
- Private prescriptions issued as needed throughout
- Regular follow-up appointments to monitor and adjust the plan
Related reading
Venlafaxine is hard to stop. That is not in question.
But with the right plan, the right pace and proper clinical support, most people can get there — steadily, safely, and without having to do it alone.